← Back to Analyst Consensus 
KMTS Buy
KESTRA MEDICAL TECHNOLOGIES, LTD.
Current Price —
Implied Upside —
Analysts 14
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 20, 2026 | Evercore ISI Group | initiate | — → Outperform | $34 | 58% |
| Sep 15, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Sep 2, 2026 | BTIG | reiterate | Buy → Buy | $32 | 52% |
| Aug 10, 2026 | JP Morgan | initiate | — → Overweight | $30 | 54% |
| Jul 21, 2026 | Oppenheimer | initiate | — → Perform | $0 | 52% |
| Jul 15, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Apr 9, 2026 | Goldman Sachs | maintain | Neutral → Neutral | $17 | 54% |
| Apr 7, 2026 | BTIG | reiterate | Buy → Buy | $32 | 52% |
| Mar 25, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Mar 18, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Dec 15, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $25 | 54% |
| Dec 12, 2025 | Wells Fargo | maintain | Overweight → Overweight | $28 | 54% |
| Dec 12, 2025 | Piper Sandler | maintain | Overweight → Overweight | $30 | 54% |
| Nov 18, 2025 | BTIG | initiate | — → Buy | $32 | 52% |
| Jul 17, 2025 | Wells Fargo | maintain | Overweight → Overweight | $27 | 54% |
| Apr 16, 2025 | Goldman Sachs | maintain | Neutral → Neutral | $23 | 54% |
| Mar 31, 2025 | Wolfe Research | initiate | — → Outperform | $29 | 53% |
| Mar 31, 2025 | Wells Fargo | initiate | — → Overweight | $28 | 54% |
| Mar 31, 2025 | Stifel | initiate | — → Buy | $28 | 53% |
| Mar 31, 2025 | Goldman Sachs | initiate | — → Neutral | $24 | 54% |
| Mar 31, 2025 | Piper Sandler | initiate | — → Overweight | $27 | 54% |
Price Target Trend
May 17, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days